Date: September 16, 2026
Board Meeting Outcomes
- The company has received listing approval from National Stock Exchange of India Limited for 40,50,000 equity shares of Re. 1/- each
- The shares were allotted pursuant to conversion of warrants issued on a preferential basis
- Approval was granted via two letters: Ref: NSE/LIST/56146 dated September 11, 2026 and Ref: NSE/LIST/56146-1 dated September 16, 2026
Specific Share Details
- Number of shares: 40,50,000 (4.05 million)
- Face value: Re. 1/- each
- Distinctive numbers: 185451981 to 189501980
Conditions and Requirements
- The shares will be listed and admitted to dealings on the Exchange upon receipt of confirmation from depositories (NSDL/CDSL) for credit of beneficiaries' accounts
- The exchange reserves the right to withdraw its in-principle approval if submitted information is found to be incomplete/incorrect/misleading/false or in contravention of any Rules, Bye-laws and Regulations